10 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... the Preventive Treatment ... of Chronic Migraine ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab
Rewarming Methods in Hypothermia
 • Passive rewarming - Requires adequate patient physiologic mechanisms. Inadequate for more
Rewarming Methods in Hypothermia ... Consider in cardiac ... Ideal method for cardiac ... #management #treatment ... #ebm
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
//www.nejm.org/doi ... ejection fraction, treatment ... causes, aborted cardiac ... hospitalization for the management ... dCHF #Cardiology #EBM
Triptan Selection - Migraine Management
Choosing triptans:
 • Reponse to given triptan do not predict to others
Triptan Selection - Migraine ... Management Choosing ... month to avoid medication-overuse ... naproxen 500mg bid) doi ... #Management #treatment
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Etiology: • Medications ... paralysis, post-hypothermia ... STOP offending medications ... line, stabilizes cardiac ... Redistribution Treatments
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
risk factors, management ... #management #medications ... Petersen EBM, Skov ... EL, Richardson IM ... (5):1821-1829. doi
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Toxic injury to BM ... - Antithyroid medications ... and thymoma DDX ... aplastic anemia Treatment ... hematology #diagnosis #management
Probiotics Guidelines
Adults with C difficile infection
 • Recommendation: Only in the context of a clinical trial
on antibiotic treatment ... Moderate/high DOI ... gastroenterology #indications ... recommendations #management ... #evidence #ebm